







































(ANSAmed) – Rome, December 1 – works in mice the first vaccine of nanospugne, a ‘molecular’ cage designed to educate the immune system and neutralize one of the most insidious bacteria: drug-resistant staph. The work carried out by researchers at … Continue reading